Daily marijuana use outpaces daily drinking in United States, new study says
From 1992 to 2022, the per-capita rate of reporting daily or near-daily marijuana use increased 15-fold.
Health Care & Insurance
Articles
Softer federal stance on marijuana could boost legalization efforts in Indiana
Some advocates wonder if the proposed reclassification of marijuana could be the game changer that opens the floodgates for legalization in the state’s 2025 legislative session.
Drugmaker Novartis to expand nuclear medicine factory near airport, creating 55 jobs
Novartis Manufacturing LLC told a committee of the City-County Council on Monday evening that it plans to spend up to $125 million to construct and equip a 79,000-square-foot-building for radiopharmaceutical manufacturing and distribution on the city’s west side.
Butler University to start four-year nursing program in 2025
The Indiana Board of Nursing has accredited the university to accept 48 students a year, meaning the program will have nearly 200 students when it is fully enrolled across four years.
Hims debuts $199 weight-loss shots, takes aim at Lilly’s Zepbound
Hims can offer the prescription weight-loss drugs because U.S. regulators have rules that allow pharmacies to make copycat versions of drugs in shortage, a practice that’s known as “compounding.”
Indiana Hospital Association names interim president
Dye takes over for longtime leader Brian Tabor, who recently said he would be stepping down from his role with IHA. Tabor joined the association in 2008 and had been president since 2016.
Justice Department formally moves to reclassify marijuana as less dangerous drug
A proposed rule sent Thursday to the federal register recognizes medical uses of cannabis and acknowledges it has less potential for abuse than some of the most dangerous drugs.
Lilly settles with spa selling knockoff versions of its popular diabetes, weight-loss drugs
In a series of lawsuits Lilly filed in September and October in federal court, the drugmaker had accused Totality Medispa of trademark infringement, false advertising, unfair competition and unfair trade practices.
Fewer U.S., Indiana overdose deaths reported last year, but experts cautious
Prescription painkillers once drove the nation’s overdose epidemic, but they were supplanted years ago by heroin and more recently by illegal fentanyl.
Lilly girding for questions over Alzheimer’s treatment from FDA committee
The U.S. Food and Drug Administration is convening a panel of independent experts on June 10 to discuss donanemab’s safety and effectiveness, including the results in patients in a clinical trial.
Indiana hospital prices remain among highest in nation, report says
In response, Indiana Hospital Association President Brian Tabor said the Rand report “continues to paint a distorted view of health care in our state.”
Hack targeting hospital chain Ascension affecting patient care
The 840-bed Ascension St. Vincent Hospital in Indianapolis is among the facilities feeling the effects of the cyberattack.
Many Indiana hospitals struggling financially amid rising expenses, report says
More than four years after the start of the COVID-19 pandemic, many Indiana hospitals are still barely breaking even and their financial viability remains at risk, according to a report released Thursday morning by the Indiana Hospital Association.
Indiana Fever lands Eli Lilly as jersey patch sponsor
Lilly and the Fever said they would also use the partnership “to close gaps on health outcomes in Indianapolis and across the state” by raising awareness of health issues.
What marijuana reclassification means for United States
The U.S. Drug Enforcement Administration is moving toward reclassifying marijuana as a less dangerous drug. Here’s a look at the possible implications.
U.S. drug control agency moving to reclassify marijuana in historic shift, sources say
The U.S. Drug Enforcement Administration will move to reclassify marijuana as a less dangerous drug, a historic shift to generations of American drug policy that could have wide ripple effects across the country.
Lilly sees quarterly profit jump 67% on demand for new weight-loss drugs
Doctors and pharmacies have reported huge demand for Mounjaro and Zepbound in recent months, causing widespread shortages of the popular drugs.
Medical practice sued after being hit by cyberattack affecting 316,000
Several victims have filed lawsuits against Otolaryngology Associates, saying the practice waited about six weeks to inform victims of the data breach.
FDA to bring lab tests under federal oversight in bid to improve accuracy, safety
The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
Biden officials indefinitely postpone ban on menthol cigarettes amid election-year pushback
The announcement is another setback for Food and Drug Administration officials, who drafted the ban and predicted it would prevent hundreds of thousands of smoking-related deaths over 40 years.